Original languageEnglish (US)
Pages (from-to)2089-2090
Number of pages2
JournalLeukemia and Lymphoma
Volume54
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Immunoconjugates
Hodgkin Disease
Antineoplastic Agents
cAC10-vcMMAE

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Brentuximab vedotin : The science of common sense. / Lunning, Matthew A; Younes, Anas.

In: Leukemia and Lymphoma, Vol. 54, No. 10, 01.10.2013, p. 2089-2090.

Research output: Contribution to journalComment/debate

Lunning, Matthew A ; Younes, Anas. / Brentuximab vedotin : The science of common sense. In: Leukemia and Lymphoma. 2013 ; Vol. 54, No. 10. pp. 2089-2090.
@article{203414a6901847de964a0479e3274c9e,
title = "Brentuximab vedotin: The science of common sense",
author = "Lunning, {Matthew A} and Anas Younes",
year = "2013",
month = "10",
day = "1",
doi = "10.3109/10428194.2013.786074",
language = "English (US)",
volume = "54",
pages = "2089--2090",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Brentuximab vedotin

T2 - The science of common sense

AU - Lunning, Matthew A

AU - Younes, Anas

PY - 2013/10/1

Y1 - 2013/10/1

UR - http://www.scopus.com/inward/record.url?scp=84884470449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884470449&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.786074

DO - 10.3109/10428194.2013.786074

M3 - Comment/debate

VL - 54

SP - 2089

EP - 2090

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 10

ER -